SCHEDULE: Ayrton Capital Discloses 9.99% Stake in PAVmed Inc.
Schedule 13G
Ayrton Capital LLC, Alto Opportunity Master Fund, and Waqas Khatri have filed a Schedule 13G reporting a 9.99% beneficial ownership stake in PAVmed Inc.
Summary
- Ayrton Capital LLC, Alto Opportunity Master Fund, and Waqas Khatri collectively report beneficial ownership of 709,069 shares of PAVmed Inc. common stock.
- The reported stake represents 9.99% of the issuer's outstanding common stock.
- The holdings consist of 49 shares of common stock, 500,000 shares of restricted common stock, and 209,020 shares issuable upon the exercise of warrants and conversion of notes.
- The warrants and notes are subject to a 9.99% beneficial ownership blocker, limiting the reporting persons' ability to exceed this threshold.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral disclosure of institutional ownership, reflecting standard investment activity rather than a fundamental shift in company performance.
Positives
- The filing indicates a significant institutional investment position in the company.
- The reporting persons have certified that the shares were acquired in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.
Negatives
- The presence of a 9.99% ownership blocker suggests the investors are intentionally limiting their voting power or regulatory reporting requirements.
Risks
- The investment includes derivative instruments (warrants and convertible notes) which are subject to market volatility and the issuer's underlying stock performance.
- The 9.99% ownership cap limits the investors' ability to increase their stake without further regulatory filings or potential market impact.
Future Outlook
The filing does not provide specific forward-looking guidance regarding the issuer's business operations, as it is a disclosure of ownership interest.
Industry Context
StockSavvy.ai notes that Schedule 13G filings are standard disclosures for institutional investors and do not typically signal a change in corporate strategy, but rather reflect the investment firm's confidence in the issuer's long-term value.
Comparison to Industry Standards
- The 9.99% ownership threshold is a common limit used by institutional investors to avoid triggering certain regulatory requirements associated with higher ownership levels.
- The use of beneficial ownership blockers is a standard practice in private investment vehicles holding convertible debt and warrants.
Stakeholder Impact
- Shareholders may view the presence of a significant institutional investor as a sign of confidence in the company's prospects.
Next Steps
- The reporting persons will continue to monitor their investment in the ordinary course of business.
Key Dates
| Date | Description |
|---|---|
| 03/27/2026 | Date of the issuer's 10-K filing used to determine outstanding share count. |
| 03/31/2026 | Date of the event requiring the filing of the statement. |
| 05/11/2026 | Date of the signature and filing of the Schedule 13G. |
Keywords
PAVmed, Schedule 13G, Ayrton Capital, Institutional Ownership, Beneficial Ownership, Convertible Notes, Warrants
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.